Related Experiment Video
Updated: Jan 10, 2026

Comparative Study on the Polysaccharide Contents and Antioxidant Activities of Hippophae rhamnoides subsp. sinensis and Hippophae gyantsensis
Published on: August 15, 2025
Phytochemical Diversity and Anti-Inflammatory, Antidiabetic and Bronchodilatory Activities of Sugandhmantri
Praveen Kumar Kashyap1,2, Monazza Israr3, Kirti Agrahari3
1Phytochemistry Division, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, Uttar Pradesh, India.
Abstract:
Homalomena aromatica (Spreng.) Schott is one of the economically important plant species in India. The current study has assessed the chemical diversity of H. aromatica collected from various locations around India. The essential oils (HA1-HA8) and supercritical CO2 extract (HA9) prepared from the rhizomes of the plant were investigated using chromatographic and spectroscopic techniques. The study revealed a rich diversity in the chemical composition and essential oil content (0.57% ± 0.03%-1.56% ± 0.05%) of the examined samples. Altogether, 84 chemical constituents, representing 75.9%-96.4% of the total composition, were identified. The major components of the essential oils were linalool (29.9%-59.2%), sabinene (<0.05%-12.3%), homalomenol D (2.3%-11.2%), germacrene d-4-ol (0.0%-10.7%) and α-cadinol (4.1%-10.3%). However, major constituents of the HA9 were linalool (10.9%), oplopanone (6.6%), α-cadinol (6.1%) and homalomenol D (5.1%). The treatment of HA1 and HA9 showed a significant decrease in pro-inflammatory cytokines (TNF-α and IL-6) without significant toxic effect in HaCaT cells. Treatment with HA1 and HA9 significantly enhanced glucose uptake in L6 myotube cells. The HA1 and its isolates (linalool and homalomenol D) exhibited a relaxation response of isolated mouse bronchial tissue precontraction in carbachol. The study revealed the rich chemical diversity and the therapeutic potential of H. aromatica.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Oral Hypoglycemic Agents: Sulfonylureas
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

